University of Maryland School of Medicine Dean Mark T. Gladwin Leads International Randomized Clinical Trials for Novel Sickle Cell Treatment
University of Maryland School of MedicineUniversity of Maryland School of Medicine Dean Mark T. Gladwin, MD will join prominent scientists and government health officials this week at a Symposium in Rio De Janeiro, Brazil, to discuss new treatments for sickle cell disease (SCD).